Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Catheter ablation for atrial fib in transthyretin and AL cardiac amyloidosis – 42% freedom from atrial arrhythmia after 2-year f/u; persistent AF recurrence has 3-fold higher risk of heart failure hospitalization and death.”
Title: Catheter ablation of atrial fibrillation in transthyretin and light-chain cardiac amyloidosis: results from the multicentre AMYL-AF study
Authors: Daniele Faccenda, Marco Bergonti, Tom De Potter, Michel Haïssaguerre, Johan Saenen, Carlo De Asmundis, Giuseppe Ciconte, Marta De Riva, Michela Casella, Jacopo Costantino, Daniel Scherr, Mikael Laredo, Patrizio Mazzone, Avi Sabbag, Matteo Anselmino, Andrea Rossi, Matteo Bertini, Lia Crotti, Christian-Hendrik Heeger, Claudio Tondo, Elena Arbelo, Moises Levinstein, Sebastiaan R. D. Piers, Maria L. Caputo, Carlo Pappone, Domenico G. Della Rocca, Olivier Van Leuven, Paolo Compagnucci, Tardu Özkartal, Raffaele Salerno, Chiara Pavone, Valeria Rella, Katharina I. Gölly, Lorenzo Gigli, Cristina Balla, Cristina Chimenti, Nicolas Johner, Alessandro Laschera, Manuela Averaimo, Esther Scheirlynck, Marco Schiavone, Cinzia Monaco, Giulio Conte
You can read the Full Article on EP Europace.
You can find other articles featuring Robert Orlowski on OncoDaily.
